Showing results (811-820 of 2,044) with videos related to

Sort By:
Pageof 205
Current Alzheimer Research|December 24, 2021
Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer's Disease in a Multiethnic PopulationMia Nishikawa, Adam M Brickman, Jennifer J Manly, et al.
Current Alzheimer Research|December 24, 2021
Effects of the Co-occurrence of Diabetes Mellitus and Tooth Loss on Cognitive FunctionHuabin Luo, Chenxin Tan, Samrachana Adhikari, et al.
Current Alzheimer Research|December 24, 2021
Oxidative Damage of Proteins Precedes Loss of Cholinergic Phenotype in the Septal Neurons of Olfactory Bulbectomized MiceO A Nedogreeva, N A Evtushenko, A O Manolova, et al.
Current Alzheimer Research|December 28, 2021
White Matter Microstructure is Associated with Serum Clusterin and Everyday Functioning in a Sample of Nondemented Older AdultsAlexandra L Clark, Seraphina K Solders, Kelsey R Thomas, et al.
Current Alzheimer Research|October 25, 2022
White Matter Damage in Alzheimer's Disease: Contribution of OligodendrocytesJinyu Zhou, Peng Zhang, Bo Zhang, et al.
Current Alzheimer Research|September 14, 2022
Trace Element Concentration and Cognitive Dysfunction in Elderly Residents in BirjandToba Kazemi, Mitra Moodi, Shahnaz Rajabi, et al.
Current Alzheimer Research|September 6, 2022
Distribution of Cortical Atrophy Associated with Cognitive Decline in Alzheimer's Disease: A Cross-Sectional Quantitative Structural MRI Study from PUMCH Dementia CohortChenhui Mao, Bo Hou, Jie Li, et al.
Current Alzheimer Research|September 6, 2022
Predictors of Healthcare Utilization Among Older Adults with Moderate to Severe Cognitive Limitations in Ghana: A Cross-Sectional Analysis of the WHO Study on Global Ageing and Adult Health (SAGE) Wave 1Baozhen Dai, Ebenezer Larnyo, Abigail Larnyo, et al.
Current Alzheimer Research|December 17, 2021
Reduced Contextual Information During Future Thinking in Alzheimer's DiseaseMohamad El Haj, Pascal Antoine
Current Alzheimer Research|August 22, 2018
Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension StudyStephen Salloway, Gad A Marshall, Ming Lu, et al.
Pageof 205